CliffBio
small molecule

LEVOTHYROXINE SODIUM

LEVOTHYROXINE SODIUM

Loss of exclusivityJuly 2036latest FDA-listed patent expiry
CompanyHikma →View the full company profile on CliffBio

Drug detail

Brand nameLEVOTHYROXINE SODIUM
Active ingredientLEVOTHYROXINE SODIUM
Strength100MCG/ML
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalMay 2021
Marketing statusRX

Listed patents

PatentExpiresType
11154498July 2036product

More from Hikma

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

LEVOTHYROXINE SODIUM patent cliff — loss of exclusivity July 2036 | CliffBio